Testing effectiveness (Phase 2)Ended earlyNCT01852110
What this trial is testing
Efficacy and Safety of MK-7622 as Adjunct Therapy in Participants With Alzheimer's Disease (MK-7622-012)
Who this might be right for
Alzheimer's Disease
Merck Sharp & Dohme LLC 240